StockData
Albemarle Corp logo

Albemarle Corp (ALB.PA) stock

ALB.PANYSEPlastic Materials, Synth Resins & Nonvulcan ElastomersFiscal year ends December 31Also trades as ALB
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3036% below fair value
$43.96+1.77 (+4.20%)

Close on Nov 5, 2026Market cap $11.61BP/E 23.8Yield 1.65%

Albemarle r&d expenses

Research and development expenses are spending on new products and technology.

Albemarle's R&D Expenses for the twelve months ending Sep 30, 2026 was $33.19M, down 44.0% year over year. For fiscal 2025 it was $51.40M, down 40.7% from the year before. Over ten years it grew -5.4% a year on average. The highest annual figure on record is $89.19M in fiscal 2015.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$51.40M-40.7%
FY2024Dec 31, 2024$86.72M+1.2%
FY2023Dec 31, 2023$85.73M+19.1%
FY2022Dec 31, 2022$71.98M+33.2%
FY2021Dec 31, 2021$54.03M-8.8%
FY2020Dec 31, 2020$59.21M+1.6%
FY2019Dec 31, 2019$58.29M-16.8%
FY2018Dec 31, 2018$70.05M-16.9%
FY2017Dec 31, 2017$84.33M+4.8%
FY2016Dec 31, 2016$80.48M-9.8%
FY2015Dec 31, 2015$89.19M+1.0%
FY2014Dec 31, 2014$88.31M+7.4%
FY2013Dec 31, 2013$82.25M+4.2%
FY2012Dec 31, 2012$78.92M+2.4%
FY2011Dec 31, 2011$77.08M+32.0%
FY2010Dec 31, 2010$58.39M-4.1%
FY2009Dec 31, 2009$60.92M-9.5%
FY2008Dec 31, 2008$67.29M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.17M-35.5%
Q2 FY2026Jun 30, 2026$3.67M-70.5%
Q1 FY2026Mar 31, 2026$9.17M-35.0%
Q4 FY2025Dec 31, 2025$12.18M-39.2%
Q3 FY2025Sep 30, 2025$12.67M-43.4%
Q2 FY2025Jun 30, 2025$12.44M-40.1%
Q1 FY2025Mar 31, 2025$14.10M-40.1%
Q4 FY2024Dec 31, 2024$20.02M-12.0%
Q3 FY2024Sep 30, 2024$22.40M+6.2%
Q2 FY2024Jun 30, 2024$20.77M-3.0%
Q1 FY2024Mar 31, 2024$23.53M+15.0%
Q4 FY2023Dec 31, 2023$22.75M+12.9%
Q3 FY2023Sep 30, 2023$21.08M+14.8%
Q2 FY2023Jun 30, 2023$21.42M+23.2%
Q1 FY2023Mar 31, 2023$20.47M+27.3%
Q4 FY2022Dec 31, 2022$20.15M+66.2%
Q3 FY2022Sep 30, 2022$18.36M+38.1%
Q2 FY2022Jun 30, 2022$17.39M+24.4%
Q1 FY2022Mar 31, 2022$16.08M+9.9%
Q4 FY2021Dec 31, 2021$12.13M-21.1%
Q3 FY2021Sep 30, 2021$13.29M-1.8%
Q2 FY2021Jun 30, 2021$13.98M-1.6%
Q1 FY2021Mar 31, 2021$14.64M-9.1%
Q4 FY2020Dec 31, 2020$15.38M+7.8%
Q3 FY2020Sep 30, 2020$13.53M-13.2%
Q2 FY2020Jun 30, 2020$14.21M+5.6%
Q1 FY2020Mar 31, 2020$16.10M+7.5%
Q4 FY2019Dec 31, 2019$14.26M-12.9%
Q3 FY2019Sep 30, 2019$15.59M-6.2%
Q2 FY2019Jun 30, 2019$13.46M-16.2%
Q1 FY2019Mar 31, 2019$14.98M-28.6%
Q4 FY2018Dec 31, 2018$16.38M-21.6%
Q3 FY2018Sep 30, 2018$16.61M-23.7%
Q2 FY2018Jun 30, 2018$16.07M-7.3%
Q1 FY2018Mar 31, 2018$20.99M-13.7%
Q4 FY2017Dec 31, 2017$20.91M+9.5%
Q3 FY2017Sep 30, 2017$21.76M–
Q2 FY2017Jun 30, 2017$17.34M–
Q1 FY2017Mar 31, 2017$24.32M–
Q4 FY2016Dec 31, 2016$19.09M–

More Albemarle figures

See a number that looks wrong?